| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $142K | +1418.6% |
| R&D Expense | $3.0M | +1567.8% |
| SG&A Expense | $2.8M | +130.8% |
| Operating Income | -$5.7M | -628.5% |
| Interest Expense | $1.5M | — |
| Pre-tax Income | -$9.5M | -52.8% |
| Net Income | -$9.5M | -942.5% |
| EPS (Diluted) | -$1.79 | +99.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $297K | +3917.2% |
| Accounts Receivable | $821 | +0.0% |
| Current Assets | $469K | +2256.0% |
| Total Assets | $906K | +4451.3% |
| Current Liabilities | $3.3M | -61.3% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $6.9M | -46.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.3M | -705.5% |
| Capital Expenditures | $336K | +674.2% |
| Investing Cash Flow | -$273K | -528.3% |
| Financing Cash Flow | $6.9M | +775.5% |
| Free Cash Flow | -$6.7M | -703.9% |
| Stockholders' Equity |
| -$21.7M |
| -152.6% |